Evidence map›Paper›PMID 40115840›Full record

ArticleJournal of clinical medicine research2025

Differentiating Between Fibromuscular Dysplasia and Takayasu Arteritis in a Patient With Juvenile Renovascular Hypertension and Marked Hypokalemia Effectively Treated With Percutaneous Transluminal Renal Angioplasty.

Ayako Ishii, Keisuke Okamura, Shogo Morisaki, Yasunori Momota, Akiko Yamashita, Kenta Hatsuse, Keisuke Kono, Hideto Sako, Akihiro Udo, Kenichiro Taniguchi and 7 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical medicine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ayako IshiiDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Keisuke OkamuraDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Shogo MorisakiDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Yasunori MomotaDepartment of Neurology, Imamura Hospital, Tosu, Saga, Japan.
Akiko YamashitaDepartment of Neurology, Imamura Hospital, Tosu, Saga, Japan.
Kenta HatsuseDepartment of Ophthalmology, Imamura Hospital, Tosu, Saga, Japan.
Keisuke KonoDepartment of Nephrology, Imamura Hospital, Tosu, Saga, Japan.
Hideto SakoDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Akihiro UdoDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Kenichiro TaniguchiDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Tomoko KosekiDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Takuro AraiDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Yoshie YodogawaDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Yoshiko ObaDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Shiori HirayamaDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Miki InoueDepartment of Cardiology and Cardiovascular Center, Imamura Hospital, Tosu, Saga, Japan.
Ichiro ImamuraDepartment of Surgery, Imamura Hospital, Tosu, Saga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renovascular hypertension (RVHT) is most commonly caused by renal artery stenosis (RAS) secondary to arteriosclerosis. Other causes of RVHT include fibromuscular dysplasia (FMD) and other rare causes, such as Takayasu arteritis (TA). A male patient in his early 20s presented with hypertension. Laboratory findings were positive for hypokalemia as well as elevations in plasma renin activity and aldosterone concentration. Plain computed tomography revealed atrophy of the right kidney, and magnetic resonance angiography revealed right RAS. A diagnosis of RVHT was suspected, and he was admitted to the cardiovascular ward. After percutaneous transluminal renal angioplasty (PTRA) to treat the right RAS, a typical course was observed with decreased blood pressure, normalizing hypokalemia, and decreased plasma renin activity and aldosterone concentration (which previously were extremely elevated). As angiography showed no remarkable arteriosclerosis of other vessels and given the patient's young age, FMD was suspected as the underlying cause of RVHT. However, the angiographic findings of RAS in the proximal renal artery and the lack of "string-of-beads" appearance were atypical for FMD. The patient had chronic inflammation, and further investigation revealed severe stenosis of the right carotid artery. The high C-reactive protein value and the thickened aortic wall in the computed tomography were the suggestive signs for TA. The patient was diagnosed with TA and started on steroid therapy. Although moderate stenosis remained after revascularization of the renal artery in this patient, hypertension improved markedly, demonstrating the effectiveness of PTRA. Given the diagnosis of TA as the underlying disease, the likelihood of recurrent RVHT due to restenosis of the renal artery remains high, and strict follow-up is thus required.

Indexed as

AldosteronePercutaneous transluminal renal angioplastyReninRenovascular hypertensionTakayasu arteritis

Identifiers

PMID40115840
PMCPMC11922628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.